INFECT IMMUN 润色咨询

INFECTION AND IMMUNITY

出版年份:暂无数据 年文章数:13641 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2022-05-16 wqstnyy

    审稿速度:1.0
    偏重的研究方向:传染病;细菌;糖尿病
    经验分享:经验有一点点

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2022-02-28 ms7000000140422300

    请问版面费多少呢?官网上没有看到

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    什么是comment?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2021-12-29 Gym璨烨

    什么是letter?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2021-09-07 ms4000001881910101

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:病原逃避
    经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2021-06-29 侧面2002

    审稿速度:3.0
    经验分享:挺不错的杂志

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2020-05-03 ILVhera

    审稿8-12周,可以催,二审比一审快点,也要两三周

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2020-02-23 huxiaoyan

    接受Case吗?wangmin1508093142 2018-09-08 00:00:00 发表:
    求问接受么

    wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2019-10-31 ILVhera

    好慢 一审48天还没回来 催稿了

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1220086, encodeId=6bc912200866a, content=审稿速度:1.0<br>偏重的研究方向:传染病;细菌;糖尿病<br>经验分享:经验有一点点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d56891415, createdName=wqstnyy, createdTime=Mon May 16 19:27:31 CST 2022, time=2022-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197964, encodeId=9cd2119e964e6, content=请问版面费多少呢?官网上没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a0b5443199, createdName=ms7000000140422300, createdTime=Mon Feb 28 10:54:06 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091894, encodeId=56c71091894aa, content=什么是comment?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091893, encodeId=a7e01091893f9, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1015308, encodeId=9a991015308b7, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:病原逃避<br>经验分享:2月提交,4月返修。三个评审中一个比较苛刻要求文字和讨论加强,一个赞许,一个给了提了意见修改。补了实验后,6月二次提交,两周内回复,两个评审满意,第一个认为还是没有针对他的意见进行修改。二次提交了修改版本,7月在线。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=09525566315, createdName=ms4000001881910101, createdTime=Tue Sep 07 10:24:57 CST 2021, time=2021-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977993, encodeId=ed9e9e79937e, content=审稿速度:3.0<br>经验分享:挺不错的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=41601946653, createdName=侧面2002, createdTime=Tue Jun 29 19:14:53 CST 2021, time=2021-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590168, encodeId=d33959016836, content=审稿8-12周,可以催,二审比一审快点,也要两三周, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Sun May 03 00:00:00 CST 2020, time=2020-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585241, encodeId=241a58524147, content=接受Case吗?<span class="quote">wangmin1508093142 2018-09-08 00:00:00 发表:<br>求问接受么</span>, beContent=wangmin1508093142 2018-09-08 00:00:00 发表: 求问接受么, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3a1b2139348, createdName=huxiaoyan, createdTime=Sun Feb 23 00:00:00 CST 2020, time=2020-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579145, encodeId=c50e5e9145be, content=好慢 一审48天还没回来 催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576397, encodeId=29d15e6397b6, content=现在在么样,楼主<span class="quote">kikishaw 2019-07-17 00:00:00 发表:<br>2个月初审没消息,发了邮件询问也不回复,急的就别投了</span>, beContent=kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/14/b2be1f0c556d7ef85ad8d100d01e905c.jpg, createdBy=2c545155218, createdName=ILVhera, createdTime=Mon Sep 16 00:00:00 CST 2019, time=2019-09-16, status=1, ipAttribution=)]
    2019-09-16 ILVhera

    现在在么样,楼主kikishaw 2019-07-17 00:00:00 发表:
    2个月初审没消息,发了邮件询问也不回复,急的就别投了

    kikishaw 2019-07-17 00:00:00 发表: 2个月初审没消息,发了邮件询问也不回复,急的就别投了

    0

共31条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分